$ALNT

Seizert Capital Partners LLC Decreases Position in Allient Inc. $ALNT

Seizert Capital Partners LLC reduced its stake in Allient Inc. by 12.5% in the third quarter, while institutional investors collectively own 61.57% of the company. Additionally, a VP at Allient sold a significant number of shares, decreasing his position by over 40%. Allient currently trades with a market cap of $1.04 billion, a PE ratio of 54.58, and has a "Hold" consensus analyst rating with an average price target of $50.33.

Original reporting
MarketBeat · MarketBeat
Published Jan 20, 2026, 3:03 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jan 20, 2026, 4:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Seizert Capital Partners LLC Decreases Position in Allient Inc. $ALNT — source image
Decision brief

The 30-second read

$ALNTBearishMed
01

Why it matters

These insider and institutional actions suggest caution but are not definitive indicators of future performance. The high PE ratio indicates growth expectations, which could be challenged if negative sentiment persists.

02

Market read

The activity signals potential short-term volatility; long-term implications depend on broader fundamentals and market conditions.

03

What to watch

Company fundamentals, upcoming earnings, or macroeconomic factors could offset the negative signals from insider activity.

Timing: Immediate to short-term

Background

Seizert Capital Partners LLC reduced its stake by 12.5% in Q3; a VP at Allient sold over 40% of his shares. The company has a market cap of $1.04 billion, PE ratio of 54.58, and a 'Hold' rating with a $50.33 price target.

Company-level read

Ticker impact

$ALNTBearishMedium confidence
Context

The news indicates a significant institutional stake reduction and insider share sale, which could suggest a cautious outlook from major shareholders.

Expected impact

Moderate decline of 5-10% in the near term if current trends persist.

Evidence & confidence

Institutional and insider actions are notable but do not definitively predict future performance; other factors such as overall market conditions and company fundamentals must be considered.

Market effects

Potentially negative impact on the company's sector if similar insider and institutional actions are observed across peers.

Limited regional impact, primarily affecting investors in the company's primary market.

Minimal

Counterpoint

The insider and institutional sales might be motivated by personal liquidity needs or portfolio rebalancing, not necessarily a negative outlook on the company's fundamentals.

Key entities

  • Seizert Capital Partners LLC

    A major institutional investor reducing its stake.

  • Allient Inc.

    The subject company with recent insider and institutional activity.

Related articles

$ALNTMedAI 8/10

Allient’s (NASDAQ:ALNT) Q2 CY2026: Strong Sales

Allient (NASDAQ:ALNT) reported Q2 CY2026 results. Revenue rose 10.2% year on year to $153.8 million, exceeding Wall Street estimates by 5.5%. Non-GAAP adjusted EPS was $0.80, up from $0.57 a year earlier and above consensus. Analysts expect revenue growth of 6.3% over the next 12 months and full-year EPS to rise from $2.44 to $2.91.

$MCHPHighAI 9/10

Stocks Jump on US-Iran Peace Optimism

US stocks rose on optimism about US-Iran peace and supportive earnings. Bloomberg Intelligence said 83% of 475 S&P 500 Q1 reporters beat estimates; Q1 earnings are projected +12% y/y (ex-tech about +3%). S&P gains were led by chip/AI and airlines as WTI fell ~3%. Rates: 10-year yield fell ~7.5 bp to 4.483%; ECB swaps price a 91% chance of a +25 bp hike.

$ACIMed

Albertsons recalls ready-to-eat items in multiple states amid salmonella-linked jalapeño investigation

Albertsons Companies said it is voluntarily recalling four ready-to-eat products containing jalapeños supplied by Taylor Farms, including items sold at Randalls in Texas. The recall followed a supplier recall tied to an ongoing federal investigation and an FDA probe of a Salmonella Javiana outbreak. FDA reported 345 illnesses in 27 states, 36 hospitalizations, no deaths.

$CMGMed

Salmonella outbreak from Mexican jalapeños reported in 27 U.S. states

U.S. health authorities are investigating a Salmonella outbreak linked to Mexican jalapeño peppers. The CDC and FDA say 345 people are ill across 27 states, with 36 hospitalizations and no deaths. The supplier, Coast Citrus Distributors, recalled peppers sent to restaurants including Chipotle and QDOBA. Chipotle removed jalapeños from some outlets and shares fell over 8% on Aug. 4.